NCT03807687

Brief Summary

This clinical data registry records information about the health status and healthcare performances received by participants affected by every type of pancreatic disease or disorder. All data (demographic, clinical, biochemical, radiological, pharmacological, genetic...) and audio and/or video recording from operative room are collected in order to be used for prospective or retrospective studies.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3,000

participants targeted

Target at P75+ for all trials

Timeline
249mo left

Started Dec 2016

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress32%
Dec 2016Dec 2046

Study Start

First participant enrolled

December 1, 2016

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

January 15, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 17, 2019

Completed
27.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2046

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2046

Last Updated

January 17, 2019

Status Verified

January 1, 2019

Enrollment Period

30 years

First QC Date

January 15, 2019

Last Update Submit

January 15, 2019

Conditions

Pancreatic DiseasesPancreatic NeoplasmsPancreatitis

Outcome Measures

Primary Outcomes (1)

  • Overall survival

    Survival from Diagnosis to time of death

    1 year

Secondary Outcomes (1)

  • Postoperative morbidity

    90 days

Study Arms (1)

Patient with pancreatic disease

Patients diagnosed with pancreatic disease evaluated at this institution.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Every patient affected by pancreatic disease admitted to General and Pancreatic Surgery Department of Verona University Hospital from 01/01/1990 to 12/01/2046

You may qualify if:

  • any type of pancreatic disease: inflammatory and neoplastic (including solid and cystic lesions)

You may not qualify if:

  • physically or mentally inability to provide consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

AOUI Verona

Verona, 37124, Italy

RECRUITING

MeSH Terms

Conditions

Pancreatic DiseasesPancreatic NeoplasmsPancreatitis

Condition Hierarchy (Ancestors)

Digestive System DiseasesDigestive System NeoplasmsNeoplasms by SiteNeoplasmsEndocrine Gland NeoplasmsEndocrine System Diseases

Study Officials

  • Claudio Bassi, Prof

    AOUI Verona

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Erica Secchettin

CONTACT

+390458126254erica.secchettin@aovr.veneto.it

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Target Duration
27 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 15, 2019

First Posted

January 17, 2019

Study Start

December 1, 2016

Primary Completion (Estimated)

December 1, 2046

Study Completion (Estimated)

December 1, 2046

Last Updated

January 17, 2019

Record last verified: 2019-01

Locations

IT(1)